| 251 | ARVNArvinas, Inc. |
$262.6M |
-30.8% |
2025 |
| 252 | OMDAOmada Health, Inc. |
$260.2M |
-4.9% |
2025 |
| 253 | SDGRSchrodinger, Inc. |
$255.9M |
-40.4% |
2025 |
| 254 | LMATLemaitre Vascular Inc |
$249.6M |
23.1% |
2025 |
| 255 | RCUSArcus Biosciences, Inc. |
$247M |
-142.9% |
2025 |
| 256 | KROSKeros Therapeutics, Inc. |
$244.1M |
35.7% |
2025 |
| 257 | STAAStaar Surgical Co |
$239.4M |
-33.6% |
2025 |
| 258 | VXRTVaxart, Inc. |
$237.3M |
6.9% |
2025 |
| 259 | KIDSOrthopediatrics Corp |
$236.3M |
-16.8% |
2025 |
| 260 | AKBAAkebia Therapeutics, Inc. |
$236.2M |
-2.3% |
2025 |
| 261 | ANABAnaptysbio, Inc |
$234.6M |
-5.6% |
2025 |
| 262 | CERSCerus Corp |
$233.8M |
-6.7% |
2025 |
| 263 | TALKTalkspace, Inc. |
$228.9M |
3.4% |
2025 |
| 264 | PBYIPuma Biotechnology, Inc. |
$228.4M |
13.6% |
2025 |
| 265 | AXGNAxogen, Inc. |
$225.2M |
-7.0% |
2025 |
| 266 | IDYAIDEAYA Biosciences, Inc. |
$218.7M |
-52.0% |
2025 |
| 267 | VNDAVanda Pharmaceuticals Inc. |
$216.1M |
-102.0% |
2025 |
| 268 | AMRNAmarin Corp PLC |
$213.6M |
-18.2% |
2025 |
| 269 | TMCITreace Medical Concepts, Inc. |
$212.7M |
-27.7% |
2025 |
| 270 | ESTAEstablishment Labs Holdings Inc. |
$211.1M |
-24.2% |
2025 |
| 271 | SIBNSI-BONE, Inc. |
$200.9M |
-9.4% |
2025 |
| 272 | SRTAStrata Critical Medical, Inc. |
$197.1M |
21.0% |
2025 |
| 273 | LFMDLifeMD, Inc. |
$194.1M |
7.4% |
2025 |
| 274 | CRONCronos Group Inc. |
$193.4M |
-4.9% |
2025 |
| 275 | LAKELakeland Industries Inc |
$192.6M |
-13.1% |
2026 |
| 276 | BTMDbiote Corp. |
$192.2M |
14.1% |
2025 |
| 277 | RYTMRhythm Pharmaceuticals, Inc. |
$189.8M |
-103.6% |
2025 |
| 278 | MRVIMaravai Lifesciences Holdings, Inc. |
$185.7M |
-70.4% |
2025 |
| 279 | STOKStoke Therapeutics, Inc. |
$184.4M |
-3.7% |
2025 |
| 280 | LFVNLifevantage Corp |
$182.6M |
2.8% |
2026 |
| 281 | GLASGlass House Brands Inc. |
$182M |
-16.3% |
2025 |
| 282 | KMDAKamada Ltd |
$180.5M |
11.2% |
2025 |
| 283 | ADAPYAdaptimmune Therapeutics PLC |
$178M |
-39.8% |
2024 |
| 284 | CYRXCryoport, Inc. |
$176.2M |
44.4% |
2025 |
| 285 | HTFLHeartflow, Inc. |
$176M |
-66.3% |
2025 |
| 286 | PHATPhathom Pharmaceuticals, Inc. |
$175.1M |
-126.3% |
2025 |
| 287 | SBCSBC Medical Group Holdings Inc |
$173.6M |
29.4% |
2025 |
| 288 | SNDXSyndax Pharmaceuticals Inc |
$172.4M |
-165.6% |
2025 |
| 289 | RGNXREGENXBIO Inc. |
$170.4M |
-113.8% |
2025 |
| 290 | DNAGinkgo Bioworks Holdings, Inc. |
$170.2M |
-183.8% |
2025 |
| 291 | MRMDMarimed Inc. |
$159.8M |
-9.1% |
2025 |
| 292 | LQDALiquidia Corp |
$158.3M |
-43.5% |
2025 |
| 293 | HRTXHeron Therapeutics, Inc. |
$154.9M |
-13.0% |
2025 |
| 294 | AIRSAirsculpt Technologies, Inc. |
$151.8M |
-7.7% |
2025 |
| 295 | MGNXMacrogenics Inc |
$149.5M |
-49.9% |
2025 |
| 296 | STIMNeuronetics, Inc. |
$149.2M |
-26.1% |
2025 |
| 297 | ELTPElite Pharmaceuticals Inc |
$148.9M |
30.1% |
2026 |
| 298 | GRALGRAIL, Inc. |
$147.2M |
-277.5% |
2025 |
| 299 | KPTIKaryopharm Therapeutics Inc. |
$146.1M |
-134.2% |
2025 |
| 300 | INFUInfuSystem Holdings, Inc |
$143.4M |
4.6% |
2025 |